Anti-tumor effect of SLPI on mammary but not colon tumor growth

Integrated Analysis of Multiple Gene Expression Profiling Datasets Revealed Novel Gene Signatures and Molecular Markers in Nasopharyngeal Carcinoma

(2012) C. Huang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Secretory Leukocyte Protease Inhibitor (SLPI) Expression and Tumor Invasion in Oral Squamous Cell Carcinoma

(2011) Jie Wen et al.   AMERICAN JOURNAL OF PATHOLOGY

Immunotherapy with SLPI over-expressing mammary tumor cells decreases tumor growth

(2011) Nicolás Amiano et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Serine leucocyte proteinase inhibitor-treated monocyte inhibits human CD4+ lymphocyte proliferation

(2011) Diego Guerrieri et al.   IMMUNOLOGY

Secretory Leukocyte Protease Inhibitor and Elafin/Trappin-2

(2010) Jean-Michel Sallenave   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancerin vitroandin vivo

(2009) Nick Devoogdt et al.   CANCER SCIENCE

Secretory Leukocyte Protease Inhibitor

(2008) Sonia A. Gomez et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer

(2008) Wan-Li Cheng et al.   INTERNATIONAL JOURNAL OF CANCER